Filing Details

Accession Number:
0001232524-15-000120
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-28 19:11:01
Reporting Period:
2015-05-26
Filing Date:
2015-05-28
Accepted Time:
2015-05-28 19:11:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615764 Iain Mcgill Connaught House, 1 Burlington Rd, Fl. 4
Dublin 4 L2
Svp, Europe And Rest Of World No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-05-26 5,834 $46.83 30,530 No 4 M Direct
Ordinary Shares Acquisiton 2015-05-26 1,500 $59.13 32,030 No 4 M Direct
Ordinary Shares Disposition 2015-05-26 7,334 $179.48 24,696 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Non-Qualified Stock Option (right to buy) Disposition 2015-05-26 5,834 $0.00 5,834 $46.83
Ordinary Shares Non-Qualified Stock Option (right to buy) Disposition 2015-05-26 1,500 $0.00 1,500 $59.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,500 2022-08-08 No 4 M Direct
5,500 2023-03-04 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.17 to $179.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  2. Following the reported transaction, the remaining ordinary shares subject to this option vest in equal monthly installments from June 9, 2015 to August 9, 2016.
  3. Following the reported transaction, the remaining ordinary shares subject to this option vest in equal monthly installments from June 5, 2015 to March 5, 2017.